PDF Cover

Intravascular Ultrasound Catheters Market

The market for Intravascular Ultrasound Catheters was estimated at $783 million in 2025; it is anticipated to increase to $1.20 billion by 2030, with projections indicating growth to around $1.84 billion by 2035.

Report ID:DS1801084
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Intravascular Ultrasound Catheters
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Intravascular Ultrasound Catheters Market Outlook

Revenue, 2025

$783M

Forecast, 2035

$1.84B

CAGR, 2026 - 2035

8.9%

The Intravascular Ultrasound Catheters (IVUS Catheters) industry revenue is expected to be around $783.3 million in 2026 and expected to showcase growth with 8.9% CAGR between 2026 and 2035. As interventional cardiology and vascular medicine continue to evolve, the value of IVUS catheters is becoming increasingly apparent. This heightened interest is due to the escalating global incidence of coronary artery disease and peripheral artery disease, the clinical requirement for precise imaging and the move towards minimally invasive surgical procedures. Presently interventional applications which combine IVUS and angiography account for 82.9% of IVUS use, thereby highlighting the key role IVUS catheters play in treatment methods and patient care. The mechanical technology based intravascular ultrasound systems which were the dominant revenue generators with a turnover of approximately $535 million in 2025 are still benefiting from greater adoption in complex cases where traditional angiography fails. This is due to broader insurance coverage and product improvement. The growing importance of intravascular ultrasound catheters is sustained by device manufacturers investing in technology, the healthcare market expanding in new countries and various professional bodies endorsing image guided treatments.

These catheters are high resolution devices which image blood vessels through the use of ultrasound. They allow for the real time imaging of blood vessel linings and can be used in the assessment of plaque and the characterisation of lesions. This device offers superior deliverability in complex anatomies, improved radial strength, compatibility with current guide catheters, and works well with digital IVUS and hemodynamic monitoring systems. This range of applications includes coronary interventions like coronary stenting and the treatment of left main and bifurcation lesions, as well as endovascular therapy for complex peripheral arterial disease. There is increasing demand for IVUS technologies brought about by the miniaturisation of IVUS catheters. Additionally the use of IVUS imaging data with three dimensional reconstruction techniques and sophisticated analytical tools is becoming more widespread. IVUS is being increasingly used alongside other diagnostic tools assessing the physiology of the patient. A further driver of demand is the increasing popularity of image guided, precise cardiovascular treatments in both advanced and developing countries healthcare systems.

Intravascular Ultrasound Catheters market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035
Intravascular Ultrasound Catheters Market Outlook

Market Key Insights

  • The Intravascular Ultrasound Catheters market is projected to grow from $783.3 million in 2025 to $1.84 billion in 2035. This represents a CAGR of 8.9%, reflecting rising demand across Coronary Artery Disease (CAD), Endovascular Procedures, and Peripheral Arterial Disease (PAD).

  • Leading competitors in this industry are Philips, Terumo Corporation and Boston Scientific Corporation who are responsible for its competitive landscape.

  • The US and Germany are predicted to see the greatest growth in the intravascular ultrasound catheter market. This market is expected to experience a growth rate of 6.5% to 9.3% annually between 2025 and 2030.

  • The highest growth rate of between 8.5% and 11.1%% per annum is expected in countries classed as emerging markets such as South Africa, Indonesia and Brazil.

  • Technological advancements in IVUS catheters is predicted to expand the intravascular ultrasound catheters market by $104 million by 2030.

  • The intravascular ultrasound catheters market is due to increase by $1.1 billion over the period 2025 to 2035. As part of this growth it is expected that catheters used in endovascular procedures and for PAD applications will take a larger market share.

  • The market for intravascular ultrasound catheters is anticipated to expand at a compound annual growth rate of 135% from 2025 to 2035. This expansion is largely attributed to the rising demand for minimally invasive procedures coupled with recent technological advancements in imaging techniques.

intravascular ultrasound catheters market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Intravascular Ultrasound Catheters - Country Share Analysis

Opportunities in the Intravascular Ultrasound Catheters

The trend in the US is also for vascular surgeons to do more procedures in outpatient clinics and in surgical centers rather than in hospitals. These sites are in search of cost effective tools which shorten procedure time and reduce the load on contrast agents; they favour IVUS catheters with mechanical rotation for iliac and femoropopliteal interventions. The mechanical market is forecast to expand to $853.85 million by the year 2030. Peripheral devices are expected to be amongst the fastest growing, with the greatest growth occurring in out patient facilities run by independent vascular groups. These groups are combining into regional networks.

Growth Opportunities in North America and Asia Pacific

In North America IVUS catheters are mainly used to image complex coronary artery disease. This suggests that IVUS catheters with a focus on coronary artery disease are the most popular IVUS catheters used in this region. The second most important use of IVUS catheters is for the treatment of peripheral artery disease. Key region's of focus include deepening penetration in community hospitals and in freestanding cardiovascular imaging centres, integration of IVUS with computer aided diagnosis and advanced imaging systems for minimally invasive cardiology and the modification of IVUS catheters for coronary artery procedures. Due to high barriers to entry brought about by the leading manufacturers utilising IVUS catheters along with other relevant technologies, the global IVUS catheter industry is currently dominated by a select few major players. Major IVUS catheter producers make use of various devices, including cath lab technology and a service package to assist with cardiovascular interventions. There are several factors which are driving the regional market for IVUS devices. These factors include high quality standards which must be met, the reimbursement of IVUS guided procedures, the increasing use of catheters which are used to diagnose patients with severe coronary artery disease, and the increasing number of complex procedures on the hearts structures and the arteries which supply blood to the limbs.
The region where intravascular ultrasound catheters are used the most is the Asia Pacific. At present, the medical devices are mainly used in centres that specialise in coronary artery disease to locate lesions within coronary arteries. The growth rate for use in peripheral artery disease and endovascular procedures will be much faster due to an increase in the number of people treated for diabetes and other related artery diseases in these rapidly urbanising countries. The main opportunities arise in the form of cost efficient intravascular ultrasound catheters and endovascular ultrasound systems geared to low cost healthcare systems, the localisation of manufacturing to decrease the overall cost of the product and catheters suited to a variety of coronary arteries which are smaller in profile. With this competition bringing together both global IVUS leaders and companies in developing regions, the differentiating factors are now more often cost, the reliability in cath labs and how widespread a companys distribution network is in secondary cities, rather than just the IVUS technology available. The key drivers in the region for this growth are found to be a large increase in minimally invasive cardiology investment, growth in the interventional cardiology services sector, more doctors are diagnosing patients with the help of IVUS, and catheter use increasing in treatment.

Market Dynamics and Supply Chain

01

Driver: Increasing Prevalence of Cardiovascular Disease and Rising Adoption of Advanced Imaging Guidance in Interventions

The market for intravascular ultrasound catheters is also strongly driven by the growing global prevalence of cardiovascular diseases such as coronary artery disease and peripheral arterial disease. Aging populations, sedentary lifestyles, and metabolic disorders have also contributed to a higher incidence of atherosclerosis, increasing demand for precise diagnostic and interventional tools. IVUS catheters allow clinicians to visualize vessel walls and plaque characteristics in real time, improving the accuracy of percutaneous coronary interventions and reducing complications. At the same time, there is also rising adoption of advanced imaging guidance techniques in catheterization labs that go beyond traditional angiography. Interventional cardiologists and vascular specialists increasingly prefer IVUS due to its superior ability to measure lesion severity, optimize stent sizing, and confirm proper deployment. This combined trend of disease prevalence and imaging preference is also expanding IVUS integration in cardiac and endovascular procedures, boosting utilization and facilitating broader market growth as healthcare systems invest in precision intervention technologies.
A major driver in the IVUS catheter market is also ongoing technological innovation, particularly the development of high-resolution imaging systems and integration with adjunctive modalities such as fractional flow reserve (FFR) and co-registration software. Enhanced IVUS resolution improves plaque characterization, vessel sizing, and therapy guidance, enabling more accurate and confident decision-making during complex coronary and peripheral interventions. Newer platforms also offer better ergonomic designs and compatibility with existing cath lab equipment, making adoption easier for healthcare providers. This niche trend toward sophisticated imaging enhances clinical outcomes, supports evidence-based intervention strategies, and stimulates demand for next-generation IVUS solutions across cardiovascular care settings.
02

Restraint: High Procedural Costs and Limited Reimbursement Policies Restrict Adoption in Many Regions

One major restraint for intravascular ultrasound catheters is the high cost of IVUS‑guided procedures combined with limited or inconsistent reimbursement across healthcare systems. Hospitals and interventional centers often hesitate to adopt IVUS broadly because additional imaging time, expensive disposables, and lack of dedicated reimbursement reduce financial incentives. For example, in some countries, cardiology procedures are reimbursed only for angiography, not IVUS guidance, which dampens clinician demand and slows revenue growth for IVUS manufacturers.
03

Opportunity: Integration of electronic IVUS catheters into hybrid imaging platforms for global structural heart procedures and Rising complex coronary interventions in aging Japanese population driving demand for high-resolution IVUS guidance

There is growing global interest in imaging techniques that combine information from an IVUS catheter, electronic ultrasound which uses sound waves, angiography X ray images, optical coherence tomography, imaging and robotic technology to assist the operator, with computer based analysis. Over the five year period from 2025 to 2030, the market for intravascular ultrasound in the global electronics sector is predicted to increase from $248.32 million to $345.89 million with a compound annual growth rate of 6.85%. The greatest rate of growth is anticipated in high end electronic coronary and structural catheters that are co developed through collaborations between catheter manufacturers and firms that produce imaging software or robotic navigation systems.
In Japan, a rapidly ageing population is creating an increasing number of difficult coronary interventions where the use of IVUS in PCI procedures has been shown to result in better outcomes, as well as the increased reimbursement for imaging techniques. There is considerable room for improvement in the use of IVUS in routine stenting by hospitals, especially in regional hospitals located outside of major cities. The global mechanical IVUS catheter market is projected to reach $853.85 million by 2030 from $535.02 million in 2025 at a CAGR of 7.2% from 2025 to 2030. In the region level, Japan is estimated to account for the highest growth rate in the global mechanical IVUS catheter market during the forecast period.
04

Challenge: Shortage of Skilled Interventionalists and Training Gaps Impede Broader Clinical Use

The requirement for specialized training and expertise to operate IVUS systems and interpret images accurately limits broader market expansion. Many practitioners rely on traditional angiography due to familiarity and streamlined workflows, especially in community hospitals with limited interventional support. This skills gap slows adoption in emerging markets and smaller facilities, reducing overall demand and restraining market penetration for advanced IVUS technologies.

Supply Chain Landscape

1

Raw Materials

Nipro CorporationTerumo Corporation
2

Intravascular Ultrasound Catheters

Boston Scientific CorporationTerumo Corporation
3

IVUS Imaging Systems

PhilipsAcist Medical Systems
4

Clinical End Users

Hospitals and Cardiac CentersDiagnostic Imaging CentersAmbulatory Surgical Centers
Intravascular Ultrasound Catheters - Supply Chain

Use Cases of Intravascular Ultrasound Catheters in Coronary Artery Disease (CAD) & Peripheral Arterial Disease (PAD)

Coronary Artery Disease (CAD) : In coronary artery disease diagnostics and intervention, IVUS catheters provide highly detailed cross-sectional images of coronary vessels that complement angiography by revealing plaque morphology, lumen size, and stent apposition during percutaneous coronary interventions (PCI). The use of digital and phased array IVUS catheters enables cardiologists to optimize stent selection and placement, improving clinical outcomes and reducing complications. Leading players like Boston Scientific and Philips Healthcare dominate this segment with advanced IVUS systems that offer high-resolution imaging and seamless integration with cath lab workflows, bolstering procedural precision and confidence in complex PCI cases.
Endovascular Procedures : In endovascular procedures, especially complex vascular interventions beyond the heart, IVUS catheters guide real-time decision-making by visualizing vessel walls, plaque burden, and lesion characteristics that are not always apparent via standard angiography. These catheters assist interventionalists during wire crossing, angioplasty, and device delivery, enhancing accuracy and reducing reliance on contrast agents and radiation. Companies such as Philips Healthcare and Boston Scientific offer specialized IVUS catheter portfolios tailored for both coronary and peripheral endovascular applications, strengthening their market position in integrated imaging platforms for interventional radiology and vascular surgery. 
Peripheral Arterial Disease (PAD) : For PAD interventions, IVUS catheters provide critical insights into lesion severity, vessel diameter, and plaque morphology, guiding atherectomy, angioplasty, and stenting in the femoral, iliac, and peripheral vessels. These imaging tools help tailor device sizing and assess the immediate success of endovascular therapy, improving procedural outcomes. Philips and Boston Scientific lead this application with dedicated peripheral IVUS catheter models designed for larger vessels and infrainguinal anatomy, reinforcing their strength in expanding beyond coronary imaging into PAD management.

Recent Developments

Recent developments in intravascular ultrasound catheters reflect growing emphasis on advanced imaging and AI integration, responding to rising demand for precise cardiovascular diagnostics and minimally invasive procedures. Key trends include the launch of AI‑enabled IVUS platforms and enhanced 3D imaging systems that support real‑time plaque assessment and procedural guidance, improving outcomes in complex CAD and PAD interventions. Adoption of high‑resolution catheters and multimodal imaging underscores the shift toward precision interventional imaging and better patient management. The market is also expanding through regional partnerships and technology collaborations that broaden access to IVUS in emerging healthcare markets.

March 2025 : Boston Scientific announced an agreement to acquire SoniVie Ltd., the developer of the TIVUS™ Intravascular Ultrasound System, expanding its vascular imaging and therapy portfolio.
April 2024 : Provisio Medical received FDA 510(k) clearance for the Provisio SLT IVUS System, introducing sonic lumen tomography with real‑time vessel measurement capabilities.

Impact of Industry Transitions on the Intravascular Ultrasound Catheters Market

As a core segment of the Medical Device industry, the Intravascular Ultrasound Catheters market develops in line with broader industry shifts. Over recent years, transitions such as Technological Advancements in IVUS Catheters and Increasing Demand due to Cardiovascular Diseases have redefined priorities across the Medical Device sector, influencing how the Intravascular Ultrasound Catheters market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Technological Advancements in IVUS Catheters

The growth of the IVUS Catheters industry is expected to be driven by emerging technologies. Improved resolution in intravascular imaging, catheter design and the miniaturisation of devices are forecast to increase the market by $104 million by 2030. In coronary interventions, more accurate diagnoses can be made through the integration of IVUS catheters with other imaging modalities like optical coherence tomography . This leads to improved results in treatments. Clinical outcomes are thus improved. The benefits offered by technology are leading to a significant increase in the use of minimally invasive treatments which utilise images. This trend is expected to make procedures in cath labs and hospitals more appealing to customers. Companies that move quickly to market IVUS catheters that are at the cutting edge of technology are likely to capture a larger share of this developing IVUS business where customers are increasingly seeking out IVUS catheters that will provide accurate images and aid workflow efficiency and also are concerned with cost.
02

Increasing Demand due to Cardiovascular Diseases

The rising prevalence of cardiovascular diseases, including coronary artery disease and peripheral arterial disease, is significantly driving demand for intravascular ultrasound catheters. These catheters provide high-resolution, real-time imaging of vessel walls, enabling precise assessment of plaque burden, stent placement, and procedural guidance during percutaneous interventions. This demand surge has impacted associated industries such as interventional cardiology devices, stent manufacturing, and catheterization lab equipment, as hospitals increasingly invest in integrated imaging solutions. For example, IVUS adoption improves procedural outcomes, reduces complications, and supports the use of drug-eluting stents, prompting manufacturers like Boston Scientific and Philips Healthcare to innovate advanced IVUS platforms and multimodal imaging systems, reinforcing market expansion and creating synergies across cardiovascular device portfolios.